Good morning, and welcome to the Boston Scientific Fourth Quarter ... we're excited to bring our Empower leadless pacemaker and modular CM system to market in 2025, likely in the second half ...

Q4 2024 Earnings Call Transcript February 5, 2025 Operator: Good morning, and welcome to the Boston Scientific Fourth Quarter 2024 Earnings Call. [Operator Instructions] Please note this event is ...

The global remote patient monitoring market, valued at US$24.39 billion in 2023, is forecasted to grow at a robust CAGR of 12.7%, reaching US$27.72 ...

Founded as a pacemaker ... Boston Scientific, Abbott and J&J’s Biosense Webster Martha said Medtronic is “significantly expanding our manufacturing capability” to meet “overwhelming customer response ...

Medtronic and Axonics — now part of Boston Scientific — have confidentially settled their long-running IP dispute.

We recently compiled a list of the 10 Best Momentum Stocks to Buy According to Hedge Funds. In this article, we are going to ...

A field safety notice was issued in December regarding a certain brand of pacemaker - Boston Scientific. The notice warned of a malfunction with devices which were manufactured before September 2018 ...

Dozens of cardiac patients of Norfolk's largest hospital have been told they are "at high risk" due to defects with their pacemakers. A field safety notice was issued in December regarding a ...

Boston Scientific, which generates most of its revenue from sales of heart devices such as pacemakers and stents, also produces equipment for diagnosing and treating a range of gastrointestinal ...